Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 3 - Drugs for disorders of the metabolism
Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
05/2003
05/30/2003WO2003043581A2 Composition and method for modulating bar/fxr receptor activity
05/30/2003WO2003043438A1 Oilseed processing
05/30/2003WO2003027248A3 Antibody inhibitors of gdf-8 and uses thereof
05/30/2003WO2003008448A3 Novel human proton-gated channels
05/30/2003WO2003005998A3 A pharmaceutical composition comprising a nicotinic receptor partial antagonist and an antiemetic agent of modulating cholinergic function
05/30/2003WO2003001204A3 Type 1 diabetes diagnostics and therapeutics
05/30/2003WO2002100328A3 Treating pain by targeting hyperpolarization-activated, cyclic nucleotide-gated channels
05/30/2003WO2002096952A3 Conjugate of a transport protein and a protein for modulation of notch signalling
05/30/2003WO2002096363A3 Method for treating fibrotic diseases or other indications
05/30/2003WO2002070509A3 Antagonists of mcp-1 function and methods of use thereof
05/30/2003WO2002062795A3 Dihydropyrazolopyridine compounds and pharmaceutical use thereof
05/30/2003WO2002041897A3 Novel pharmaceutical compositions with anti-diabetic activity and method for preparing same
05/30/2003WO2002036116A9 Tripeptidyl peptidase inhibitors
05/30/2003WO2002036109A3 Use of pyridoxamine for the treatment and inhibition of obesity-related complications
05/30/2003WO2002016313A3 Integrin receptor inhibitors
05/30/2003WO2002000692A9 Pd-l2 molecules: pd-1 ligands and uses therefor
05/30/2003WO2001080823A3 Composition exhibiting enhanced formulation stability and delivery of tropical active ingredients
05/30/2003CA2467752A1 Piperidin-2-one derivative compounds and pharmaceutical composition comprising the same as active ingredient
05/30/2003CA2467729A1 Functional acylglycerides
05/30/2003CA2467095A1 Hypertonia treatment during the acute phase of a cerebrovascular accident
05/30/2003CA2466925A1 Substituted heteroarylalkanoic acids and their use as aldose reductase inhibitors
05/30/2003CA2466733A1 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
05/30/2003CA2466491A1 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
05/30/2003CA2466072A1 Substituted indolizine-like compounds and methods of use
05/30/2003CA2463790A1 Cyclic amp phosphodiesterase 4d7 isoforms and methods of use
05/29/2003US20030100771 Method for the production of l-ascorbic acid by lactonisation of 2-keto-l-gulonic acid or s2-keto-l-gulonate esters
05/29/2003US20030100770 D-proline derivatives
05/29/2003US20030100609 Orally ingesting a quantity of calcium formate sufficient to improve calcium balance or retention
05/29/2003US20030100608 1,4-disubstituted benzo-fused cycloalkyl urea compounds
05/29/2003US20030100607 Thiolalkyl benzoic acid derivatives
05/29/2003US20030100603 Administering to the patient subject to a C-reactive protein associated inflammatory condition, an effective amount of a non-alpha-tocopherol enriched tocopherol
05/29/2003US20030100599 2-amino-fluorene derivatives useful for prophylactic and/or therapeutic treatment of diseases and conditions associated with alpha 4 intergrins or their ligands
05/29/2003US20030100596 Arylsulphonyl substituted-tetrahydro- and hexahydro-carbazoles
05/29/2003US20030100594 Carbonic anhydrase inhibitor
05/29/2003US20030100587 New substituted 2,4-thiazolidinedione derivatives, processes for producing them and pharmaceutical compositions containing them
05/29/2003US20030100585 For example 3-(2-(1-(2-(3-Methoxy-4-(3-o-tolyl-ureido)-phenyl)-acetylamino )- 3-methyl-butyl)-4,5-dihydro-oxazol-5-yl)-2-methyl-propionic acid
05/29/2003US20030100571 Such as 2-((6-(((4-(3,4-dimethoxyphenyl)methyl)amino)-7-ethyl-7H-purin-2-yl)amino) -4,5-methyl-N-phenyl-5-thiazole-carboxamide for treatment of lymphocyte mediated diseases such as transplant rejection and graft versus host disease
05/29/2003US20030100570 Immunomodulation and effect on cell processes relating to serotonin family receptors
05/29/2003US20030100567 Tyrosine kinase inhibitors
05/29/2003US20030100563 Such as 7-((3R)-3-amino-4-(3,4-difluorophenyl)butanoyl)-2-(trifluoromethyl)-5,6,7,8 -tetrahydroimidazo(1,2-a)pyrazine dihydrochloride for treatment of insulin resistance disorders
05/29/2003US20030100561 Treatment of insulin resistance with growth hormone secretagogues
05/29/2003US20030100556 Such as (S)-N-(5-(4-Methylpiperazin-1-yl)-3,4-dihydro-2H-1-benzopyran-3-yl)-4 -morpholinobenzamide for treatment of mood/anxiety/eating disorders
05/29/2003US20030100548 Antiarthritic agents; atherosclerosis and chronic obstructive pulmonary disease treatments
05/29/2003US20030100542 5-hydroxysapogenin derivatives with anti-dementia activity
05/29/2003US20030100526 Operably linked mammalian muscle creatine kinase promoter, mammalian desmin promoter and enhancers thereof, and vertebrate troponin I IRE enhancer; gene therapy
05/29/2003US20030100510 Crystallized structure of type IV collagen NC1 domain hexamer
05/29/2003US20030100504 Treatment and diagnosis of insulin-resistant states
05/29/2003US20030100490 For therapy of arthritis, inflammatory dermatosis, inflammatory bowel disease, cancer, kidney fibrosis, inflammatory lung disease, obesity, lupus, cardiovascular disease and diabetes mellitus
05/29/2003US20030100488 Osteoprotegerin binding proteins
05/29/2003US20030100486 Inflammatory markers as tools in the detection and prevention of diabetes mellitus and as tools to aid in the selection of agents to be used for the prevention and treatment of diabetes
05/29/2003US20030100034 Detection of modulators of cell activity; obtain cell, incubate with modulator, measure the concentration of target polypeptide, evaluate for cancer
05/29/2003US20030100014 Apolipoprotein biopolymer markers predictive of type II diabetes
05/29/2003US20030100010 Fibrinogen biopolymer Marker predictive of type II diabetes
05/29/2003US20030100009 Inter alpha trypsin inhibitor biopolymer markers indicative of insulin resistance
05/29/2003US20030099747 Thickened oil compositions of edible oil
05/29/2003US20030099694 Method for the improvement of transport across adaptable semi-permeable barriers
05/29/2003US20030099661 Compositions and methods for the treatment of immune related diseases
05/29/2003US20030099626 Mixture of various Aspergillus derived enzymes such as protease, lipase, amylase and cellulase and mineral cofactors such as calcium, zinc, manganese, and magnesium compounds
05/28/2003EP1314732A2 Substituted pyrimidine compounds and their use
05/28/2003EP1314731A2 Substituted pyrimidine compounds and their use
05/28/2003EP1314729A1 Biologically active 4H-benzo(1,4)oxazin-3-ones
05/28/2003EP1314723A1 Branched chain amino acid-dependent aminotransferase inhibitors and their use in the treatment of neurodegenerative diseases
05/28/2003EP1314721A1 Novel propenohydroxamic acid derivatives
05/28/2003EP1314434A2 Agent for regulating lipidic metabolism and method for producing said agent
05/28/2003EP1314427A1 Remedial agent for osteoporosis
05/28/2003EP1314426A1 Branched chain amino acid-dependent aminotransferase inhibitors and their use in the treatment of neurodegenerative diseases
05/28/2003EP1314423A1 Medicinal compositions
05/28/2003EP1313874A1 Pharmaceutical compositions comprising a modulator of adamts-1
05/28/2003EP1313843A2 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
05/28/2003EP1313769A2 Antibodies to human il-1 beta
05/28/2003EP1313733A1 Pyrazolopyridine compound and pharmaceutical use thereof
05/28/2003EP1313726A1 Quinoline derivatives having vegf inhibiting activity
05/28/2003EP1313718A2 Inhibitors of copper-containing amine oxidases
05/28/2003EP1313717A1 Oxazolyl-arylpropionic acid derivatives and their use as ppar agonists
05/28/2003EP1313716A1 Oxazolyl-arylpropionic acid derivatives and their use as ppar agonists
05/28/2003EP1313715A1 Oxazolyl-aryloxyacetic acid derivatives and their use as ppar agonists
05/28/2003EP1313714A1 Valsartan salts
05/28/2003EP1313711A2 Indazole derivatives as jnk inhibitors
05/28/2003EP1313710A1 Pyrazole derivatives and their use as protein kinase inhibitors
05/28/2003EP1313705A1 Gem-substituted alpha v beta 3 integrin antagonists
05/28/2003EP1313696A2 Amino(oxo)acetic acid protein tyrosine phosphatase inhibitors
05/28/2003EP1313501A2 Functions for dp214
05/28/2003EP1313496A1 Use of a composition comprising an extract of pollen for the treatment of edema
05/28/2003EP1313495A1 Use of a composition comprising an extract of pollen for the treatment of hormonally-related disorders
05/28/2003EP1313494A1 Use of a composition comprising an extract of pollen for the treatment of disease-related weight gain
05/28/2003EP1313493A1 Use of a composition comprising an extract of pollen for the treatment of irritability
05/28/2003EP1313492A1 Use of a composition comprising an extract of pollen for the treatment of dysphoria
05/28/2003EP1313483A2 Methods for inducing apolipoprotein e secretion
05/28/2003EP1313470A1 Novel alicyclic imidazoles as h 3 agents
05/28/2003EP1313465A1 Composition and method for treatment of hypertriglyceridemia
05/28/2003EP1313461A2 The use of benzylideneaminoguanidines and hydroxyguanidines as melanocortin receptor ligands
05/28/2003EP1313453A1 Particulate vectors for improving oral absorption of active principles
05/28/2003EP1313450A1 A method of treating a systemic disease
05/28/2003EP1243275A4 Insulin-containing medicament for peroral application and method for the production thereof
05/28/2003EP1231211B1 Thiazolidinedione derivatives as antidiabetic agents
05/28/2003EP1189903B1 Novel benzo[f]naphthyridine, preparation and compositions containing them
05/28/2003EP1163239B1 Modified amino-acid amides as cgrp antagonists
05/28/2003EP1140188B1 Combinations of ileal bile acid transport inhibitors and cholesteryl ester transfer protein inhibitors for cardiovascular indications
05/28/2003EP1097145B1 Polyhydroalkylpyrazine derivatives and their preparation and medicines containing them
05/28/2003EP1056358B1 Use of d-tagatose as a prebiotic food component
1 ... 901 902 903 904 905 906 907 908 909 910 911 912 913 914 915 916 917 918 919 920 921 ... 1298